Darilong 7.5 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. Urinary Incontinence are some of its major therapeutic uses. Secondary and off-label uses of Darilong 7.5 Mg Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Darilong 7.5 Mg Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Darilong 7.5 Mg Tablet can also lead to other problems, which have been listed below. These side effects of Darilong 7.5 Mg Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Darilong 7.5 Mg Tablet's effect during pregnancy is Moderate and Moderate while nursing. In addition, Darilong 7.5 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Darilong 7.5 Mg Tablet related warnings section.
Other contraindications of Darilong 7.5 Mg Tablet have been discussed in the sections ahead.
Drug interactions for Darilong 7.5 Mg Tablet have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Darilong 7.5 Mg Tablet is considered not safe while driving, and is not addictive.
Darilong 7.5 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Darilong 7.5 Mg Tablet is used -
Moderate
Mild
Unknown
Is the use of Darilong 7.5 Mg Tablet safe for pregnant women?
Darilong can have harmful effects in pregnant women. If you experience any discomfort after using Darilong, then discontinue the use and take your doctor's advice.
Is the use of Darilong 7.5 Mg Tablet safe during breastfeeding?
Darilong can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Darilong 7.5 Mg Tablet on the Kidneys?
Darilong is not harmful for kidneys.
What is the effect of Darilong 7.5 Mg Tablet on the Liver?
Very few cases of side effects of Darilong on the liver have been reported.
What is the effect of Darilong 7.5 Mg Tablet on the Heart?
Darilong has very mild side effects on the heart.
Darilong 7.5 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Darilong 7.5 Mg Tablet unless your doctor advises you to do so -
Is this Darilong 7.5 Mg Tablet habit forming or addictive?
Darilong 7.5 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Darilong 7.5 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Darilong 7.5 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Darilong 7.5 Mg Tablet in mental disorders is not effective.
Interaction between Food and Darilong 7.5 Mg Tablet
Taking Darilong 7.5 Mg Tablet with food does not harm your health.
Interaction between Alcohol and Darilong 7.5 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Darilong 7.5 Mg Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 401
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Enablex® (darifenacin)
